Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma.
A M
AM
Abdou
X
X
Gao
W
W
Cozen
J R
JR
Cerhan
N
N
Rothman
M P
MP
Martin
S
S
Davis
M
M
Schenk
S J
SJ
Chanock
P
P
Hartge
M
M
Carrington
S S
SS
Wang
D016022:Case-Control Studies; D004247:DNA / Q000032:analysis / Q000235:genetics; D014644:Genetic Variation / Q000235:genetics*; D015788:HLA-A1 Antigen / Q000235:genetics*; D015795:HLA-B8 Antigen / Q000235:genetics*; D015803:HLA-DR3 Antigen / Q000235:genetics*; D006239:Haplotypes / Q000235:genetics*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000145:classification / Q000235:genetics* / Q000473:pathology; D011379:Prognosis; D018426:SEER Program; D015996:Survival Rate; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
D015788:HLA-A1 Antigen; D015795:HLA-B8 Antigen; D015803:HLA-DR3 Antigen; D014409:Tumor Necrosis Factor-alpha; D004247:DNA